BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3972987)

  • 1. Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth.
    Heifets LB; Iseman MD
    J Clin Microbiol; 1985 Feb; 21(2):200-4. PubMed ID: 3972987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
    Tarrand JJ; Spicer AD; Gröschel DH
    Antimicrob Agents Chemother; 1986 Dec; 30(6):852-5. PubMed ID: 3101586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method.
    Salfinger M; Heifets LB
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1002-4. PubMed ID: 3142340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating current methods for determination of the susceptibility of mycobacteria to pyrazinamide, conventional, radiometric Bactec and two methods of pyrazinamidase testing.
    Cutler RR; Wilson P; Villarroel J; Clarke FV
    Lett Appl Microbiol; 1997 Feb; 24(2):127-32. PubMed ID: 9081306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
    Salfinger M; Reller LB; Demchuk B; Johnson ZT
    Res Microbiol; 1989; 140(4-5):301-9. PubMed ID: 2508202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg-yolk-enriched BACTEC 12A medium.
    Woodley CL; Smithwick RW
    Antimicrob Agents Chemother; 1988 Jan; 32(1):125-7. PubMed ID: 3126704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of growth and susceptibility testing of pyrazinamide in different Bactec media using strains of the M. tuberculosis complex.
    Fuursted K
    APMIS; 1993 Feb; 101(2):154-9. PubMed ID: 8489766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay.
    Syre H; Øvreås K; Grewal HM
    J Antimicrob Chemother; 2010 Apr; 65(4):704-12. PubMed ID: 20118493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazinamide is not active in vitro against Mycobacterium avium complex.
    Heifets LB; Iseman MD; Crowle AJ; Lindholm-Levy PJ
    Am Rev Respir Dis; 1986 Dec; 134(6):1287-8. PubMed ID: 3789528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations.
    Heifets L; Lindholm-Levy P
    Am Rev Respir Dis; 1992 May; 145(5):1223-5. PubMed ID: 1586071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test].
    Yamane N; Nakasone I; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test.
    Aono A; Hirano K; Hamasaki S; Abe C
    Diagn Microbiol Infect Dis; 2002 Dec; 44(4):347-52. PubMed ID: 12543539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MGIT 960 & pyrazinamidase activity assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
    Sharma B; Pal N; Malhotra B; Vyas L; Rishi S
    Indian J Med Res; 2010 Jul; 132():72-6. PubMed ID: 20693593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system.
    Salfinger M; Crowle AJ; Reller LB
    J Infect Dis; 1990 Jul; 162(1):201-7. PubMed ID: 2113074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
    Aragón LM; Garrigó M; Moreno C; Español M; Coll P
    J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Heifets L; Sanchez T
    J Clin Microbiol; 2000 Apr; 38(4):1498-501. PubMed ID: 10747133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system.
    Kontos F; Nicolaou S; Kostopoulos C; Gitti Z; Petinaki E; Maniati M; Anagnostou S; Raftopoulou A; Papageorgiou P; Scrioubellou A; Tselentis I; Maniatis AN
    J Microbiol Methods; 2003 Oct; 55(1):331-3. PubMed ID: 14500027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mycobacteria by radiometric and standard plate procedures.
    Damato JJ; Collins MT; Rothlauf MV; McClatchy JK
    J Clin Microbiol; 1983 Jun; 17(6):1066-73. PubMed ID: 6348076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Butler WR; Kilburn JO
    J Clin Microbiol; 1982 Dec; 16(6):1106-9. PubMed ID: 6819309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a radiometric technique for rapid sensitivity testing of mycobacteria in Scotland: the first year's experience.
    Rayner A; Harris G; Croughan M; Watt B
    Scott Med J; 1990 Oct; 35(5):142-4. PubMed ID: 2124000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.